Medtronic (MDT) return on equity (ROE)

Return on equity · fiscal 2026
9.7%

Medtronic (MDT) earned a return on equity of 9.7% in fiscal 2026 (the year ended April 30, 2026). That is level with fiscal 2025. Figures as of 17 Nov 2026, 22:15 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2026
9.7%
Change on fiscal 2025
−0.0 pts
Highest on record
18.6%fiscal 2013
Lowest on record
5.0%fiscal 2015
Fiscal years on record
142013–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Medtronic return on equity (ROE), in more detail

Across the 14 fiscal years on record (2013–2026), the highest was 18.6% in fiscal 2013 and the lowest 5.0% in fiscal 2015. The fiscal 2026 figure is higher than in 77% of the 13 earlier fiscal years on record, whose median is 8.0%.

History · 14 fiscal years

Return on equity by fiscal year

Medtronic return on equity (ROE), year by year

Medtronic (MDT) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
20269.7% 0.0 pts
20259.7% 2.4 pts up
20247.3% 0.0 pts
20237.3% 2.3 pts down
20229.6% 2.6 pts up
20217.0% 2.4 pts down
20209.4% 0.2 pts up
20199.2% 3.1 pts up
20186.1% 1.9 pts down
20178.0% 1.2 pts up
20166.8% 1.8 pts up
20155.0% 10.7 pts down
201415.8% 2.8 pts down
201318.6%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Medtronic and comparable companies
CompanyReturn on equityFiscal year
Vertex Pharmaceuticals VRTX21.2%2025
Medtronic MDT9.7%2026
Bristol-Myers Squibb BMY38.2%2025
Stryker SYK14.5%2025
McKesson MCK17.7%2020
Sanofi SNY10.9%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MDT

Medtronic, figure by figure

Medtronic (MDT) overview: price, valuation and scorecardAll health care companies by market value

Medtronic return on equity (ROE): questions and answers

What is Medtronic's return on equity?

Medtronic (MDT) earned a return on equity of 9.7% in fiscal 2026 (the year ended April 30, 2026). That is level with fiscal 2025.

Is Medtronic's return on equity high or low compared with its own history?

The fiscal 2026 figure is higher than in 77% of the 13 earlier fiscal years on record, whose median is 8.0%.

What are the highest and lowest return on equity figures on record for Medtronic?

Across the 14 fiscal years on record (2013–2026), the highest was 18.6% in fiscal 2013 and the lowest 5.0% in fiscal 2015.

How is Medtronic's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Medtronic (MDT) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/MDT/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.